$16.5 Billion is the total value of Polar Capital Holdings Plc's 321 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2020 | ||||||||
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 15 | Q2 2024 | 5.8% |
| APPLE INC | 15 | Q2 2024 | 4.7% |
| NVIDIA CORPORATION | 15 | Q2 2024 | 7.8% |
| ALPHABET INC | 15 | Q2 2024 | 3.3% |
| META PLATFORMS INC | 15 | Q2 2024 | 4.0% |
| ALPHABET INC | 15 | Q2 2024 | 3.0% |
| ADVANCED MICRO DEVICES INC | 15 | Q2 2024 | 3.0% |
| ARCH CAP GROUP LTD | 15 | Q2 2024 | 2.5% |
| AMAZON COM INC | 15 | Q2 2024 | 2.3% |
| CHUBB LIMITED | 15 | Q2 2024 | 1.9% |
View Polar Capital Holdings Plc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | February 13, 2024 | 6,297,688 | 6.7% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2024 | 6,751,782 | 7.5% |
| Celldex Therapeutics, Inc. | February 13, 2024 | 3,135,871 | 5.7% |
| NanoString Technologies Inc | February 13, 2024 | 3,975,000 | 8.3% |
| Revance Therapeutics, Inc. | February 13, 2024 | 3,169,239 | 3.6% |
| Spyre Therapeutics, Inc. | February 13, 2024 | 500,000 | 1.0% |
| Aeglea BioTherapeutics, Inc. | July 28, 2023 | 3,936,198 | 5.0% |
| INFINITY PHARMACEUTICALS, INC. | February 14, 2023 | 2,071,242 | 2.3% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Summit Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Polar Capital Holdings Plc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| SC 13G | 2024-02-13 |
View Polar Capital Holdings Plc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.